AB58. Phase II study of safety and clinical outcome for Nimotuzumab and concurrent capecitabine and radiotherapy for patients with locally advanced inoperable or relapsed/ residual gastric cancer

Ning-Ning Lu, Jing Jin, Ye-Xiong Li, Hua Ren, Hui Fang, Yue- Ping Liu, Wei-Hu Wang, Shu-Lian Wang, Yong-Wen Song